Teledermatology is an effective method for delivering health care, with strong evidence supporting its use, yet barriers have stalled implementation, including lack of reimbursement, liability concerns, and licensing restrictions.1,2 The coronavirus disease 2019 (COVID-19) pandemic crisis led to rapid adoption of telemedicine to continue care while minimizing in-person contact.3
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: January 23, 2021.
Published Online: March 31, 2021. doi:10.1001/jamadermatol.2021.0195
Corresponding Author: Jules B. Lipoff, MD, Penn Medicine University City, 3737 Market St, Ste 1100, Philadelphia, PA 19104 (email@example.com).
Author Contributions: Dr Hopkins had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Mr Kennedy and Ms Arey contributed equally and are co-first authors.
Concept and design: Kennedy, Arey, Tejasvi, Farah, Secrest, Lipoff.
Acquisition, analysis, or interpretation of data: Arey, Hopkins, Tejasvi, Secrest, Lipoff.
Drafting of the manuscript: Kennedy, Arey, Hopkins, Tejasvi, Farah, Lipoff.
Critical revision of the manuscript for important intellectual content: Kennedy, Arey, Hopkins, Tejasvi, Secrest, Lipoff.
Statistical analysis: Hopkins.
Administrative, technical, or material support: Kennedy, Arey, Secrest, Lipoff.
Supervision: Tejasvi, Farah, Secrest, Lipoff.
Conflict of Interest Disclosures: Dr Secrest is supported by a Public Health Career Development Award from the Dermatology Foundation. Dr Lipoff has served as a paid consultant on telemedicine for Havas Life Medicom and as telemedicine advisor for AcneAway, a direct-to-consumer teledermatology start-up. No other disclosures were reported.
Additional Contributions: This survey study was developed by a subgroup for the American Academy of Dermatology (AAD) Teledermatology Task Force, which, in addition to the authors, included George Han, MD, Linda Camaj Deda, BS, Rebecca Goldberg, BS, and Jason G. Mathis, MD, who all assisted with survey design and data analysis. Data management and analysis at the AAD was led by Rosie Balk, MA and Jeff Miller, PhD. We thank the AAD for providing access to their membership and facilitating survey implementation. We also thank Martha Wojtowycz, PhD, for her assistance with survey question validation. None of these contributors was compensated for their work on this article.
You currently have no searches saved.
You currently have no courses saved.